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Cherry stems (CS) represent a by-product intensively used in Eastern European countries
as a traditional remedy for urinary tract disorders. Ethnopharmacological evidences sustain
the use of CS as aqueous preparations (infusion and decoction), but few data were
previously reported about phytochemical profile and pharmacological potential of CS
hydroalcoholic extracts. In this regard, we aimed to evaluate the phenolic profile, in vitro
antioxidant and tyrosinase inhibitory potential, and in vivo diuretic activity of 70%
hydroethanolic cherry stems extract and cherry stems decoction (CSD). LC-DAD-ESI/
MSn analysis revealed the presence of flavonoid-type compounds as main constituents for
both preparations, especially flavanones (naringenin glycosides). Antioxidant activity
evaluated through DPPH, ABTS, and FRAP methods was superior for cherry stems
extract, probably due to the presence of phenolic-derived compounds in higher amounts
than CSD. On the other hand, tyrosinase inhibitory potential and diuretic effect exerted by
CSD were stronger, highlighting that other types of hydrophilic secondary metabolites are
responsible for this bioactivity. Overall, our findings indicate that CS preparations could be
used as promising mild diuretic agents and encourage further investigations regarding the
correlation between their chemical composition and bioactive potential.
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INTRODUCTION
In last decades, the importance of plant-derived bioactive compounds was intensively studied,
highlighting their impact on human health as modulators of metabolic pathways and processes
involved in the development of different pathological conditions. Even though dietary intake can
provide high amounts of plant-derived secondary metabolites, food habits and nutritional quality of
our meals upset the balance between the real need and consumption of these compounds. According
to Bailey (2020), more than 50% of U.S. adult population use dietary supplements; a study on E.U.
food supplement market conducted by European Commission estimates that 50% of these products
are based on vitamins and minerals, 43% food supplements containing other substances, and 7%
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Babotă M, Voştinaru O, Păltinean R,
Mihali C, Dias MI, Barros L,
Ferreira ICFR, Mocan A, Crişan O,
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tonics and bottled nutritional drinks (classified as OTC products
or marketed as functional foods) (European Advisory Services
(EAS), 2007). Hence, the interest for this type of products is in a
continuous and exponential increase, explaining the actual trends
in the research for novel and sustainable resources for food
supplements industry.
By-products resulted from the processing of different herbal
resources are intensively promoted as promising sources of
bioactive compounds, being recognized as cheap, eco-friendly,
and sustainable alternatives for standard raw materials (Fierascu
et al., 2020). Moreover, recent studies have proven that high
amounts of secondary metabolites can be concentrated in plant
by-products; for example, it was shown that an important fraction
from total polyphenolic content of several by-products from food
industry can be found as bound form, namely non-extractable
polyphenols (NEP), which exerts significant antitumor,
antioxidant, and hypocholesterolemiant properties (Dzah et al.,
2020). Therefore, it can be assumed that one of the big goals for
the future is the valorification of more and more by-products as
main sources of phytochemicals with health-related properties.
Cherry stems (CS) are one of the main by-products obtained
after the harvesting and processing of sweet cherries (Prunus
avium) and sour cherries (Prunus cerasus). Even though these are
generally recognized as a waste for food industry, the folk
medicine recommends them as a traditional herbal remedy,
especially for its diuretic and sedative properties; the herbal
drug is known by its Latin botanical name (Cerasorum
stipites), being used as infusion or decoction (Bastos et al.,
2015; Aires et al., 2017; Švarc-Gajić et al., 2018; Nastić et al.,
2020; Peixoto et al., 2020). According to the Committee on
Herbal Medicinal Products (HMPC) of European Medicines
Agency, CS can be used single or as herbal tea combinations
with other herbal substances used in the therapeutic area for
“urinary tract disorders,” generically named Species diureticae
(Länger, 2017). In Central and Eastern European countries,
especially in Romania, based on ethnopharmacological
recommendations, the herbal product is recognized as a
popular remedy in the adjuvant treatment of kidney stones,
mild urinary tract infections, edema, and hypertension. In
Encyclopedia of Romanian ethnobotany, Butura et al. describe
the use of CS as infusions or decoctions in intra-Carpathic areas
in the treatment of kidney disorders; different traditional recipes
for decoctions were reported, obtained from both stems and
crushed stones from cherries or herbal mixtures including aerial
parts of horsetail (Equisetum arvense), leaf buds of mountain pine
(Pinus mugo), and corn stigmas (Zea mays) (Butura, 1979). Being
one of the most popular herbal products with diuretic properties
in Romanian folk medicine, pharmacies and markets sell CS-
containing products conditioned as teas or capsules,
recommended as adjuvant therapy in kidney stones, cystitis, or
obesity (Pârvu, 2006).
Few phytochemical and pharmacological investigations were
conducted on CS. Most of the studies available on this topic are
from last 5 to 10 years, being focused both on qualitative and
quantitative evaluation of the main constituents in the extracts
and the assessment of their potential bioactivities. In a
comparative study between fruits and stems focused on
hydrophilic compounds profile, Bastos et al. showed that
stems are rich in citric, malic, and oxalic acids (Bastos et al.,
2015). In the same study, phenolic profile of hydroalcoholic
extracts obtained from stems was evaluated; sakuranetin-5-
O-glucoside, catechin, naringenin-7-O-glucoside, and
aromadendrin-7-O-hexoside were quantified as main
compounds. Other studies revealed the presence of
hydroxycinnamic acids (cis-3-O-p-coumaroylquinic acid,
chlorogenic acid, and trans-3-O-p-coumaroylquinic acid):
quercetin and sinapic acid in high amounts (Demir et al.,
2020; Peixoto et al., 2020). In this regard, corroborated with
the occurrence of these compounds, several in vitro bioactivities
were proven for CS extracts: antioxidant, antitumor, antidiabetic,
and antibacterial (Bastos et al., 2015; Aires et al., 2017; Demir
et al., 2020; Peixoto et al., 2020).
Except for the in vitro antibacterial effect on E. coli strains, few
studies were focused on the evaluation of the real benefits of CS in
the treatment of urinary tract disorders based on pharmacological
investigation (Aires et al., 2017). Hence, the present study aimed
to evaluate phenolic profile and pharmacological properties of
two different types of extracts obtained from CS (hydroethanolic
and aqueous decoction). LC-DAD-ESI/MSn technique was
employed for both qualitative and quantitative analysis of
several phenolic compounds, followed by in vitro evaluation of
antioxidant and tyrosinase inhibitory activities. In vivo diuretic




Acetonitrile (99.9%) was of HPLC grade from Fisher Scientific
(Lisbon, Portugal). Phenolic compound standards (chlorogenic
acid, ferulic acid, naringenin, p-coumaric acid, quercetin-3-O-
glucoside, quercetin-3-O-rutinoside, and taxifolin) were from
Extrasynthèse (Genay, France). Formic acid was purchased
from Sigma-Aldrich (St. Louis, MO, United States). All other
general laboratory reagents were purchased from Panreac
Química S.L.U. (Barcelona, Spain). Water was treated by using
a Milli-Q water purification system (TGI Pure Water Systems,
Greenville, SC, United States). Ferric chloride; 6-hydroxy-2,5,7,8-
tetramethylchromane-2-carboxylic acid (Trolox) (97%);
diammonium 2,2′-azino-bis(3-ethylbenzothiazoline-6-
sulfonate) (ABTS) (>98%); 2,2-diphenyl-1-(2,4,6-
trinitrophenyl) hydrazine (DPPH); 2,4,6-tris (2-pyridyl)-s-
triazine (TPTZ) (≥99%); dimethyl sulfoxide (DMSO) (≥99%);
phosphate buffer, mushroom tyrosinase; 3,4-dihydroxy-
L-phenylalanine (L-DOPA) (≥98%); and kojic acid were
purchased from Sigma (Sigma-Aldrich Chemie GmbH,
Schnelldorf, Germany). All other reagents used, including
solvents, were of analytical grade.
Plant Material
CS were purchased from a community pharmacy in Cluj-Napoca,
Romania, as herbal tea conditioned in toto (raw material).
Samples were ground to a fine powder using a laboratory mill,
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sieved and immediately subjected to extraction. The quality of
samples was analyzed and confirmed after organoleptic and
macroscopic control by Dr. Andrei Mocan from Department
of Pharmaceutical Botany, Faculty of Pharmacy, “Iuliu
Hatieganu” University of Medicine and Pharmacy (Cluj-
Napoca, Romania).
Extraction Procedure
Maceration: 100 g CS powder previously weighed and transferred
in an Erlenmeyer flask was mixed with 500 ml of 70% (v:v)
ethanol, being shaken and kept at room temperature in a dark
place for 72 h. After filtration, the residue was re-extracted with
500 ml of solvent in the same condition for other 6 days. The
extracts were reunited in a round-bottom flask and the alcohol
was evaporated under reduced pressure. The aqueous suspension
obtained was further lyophilized; the dry CS extract (CSE) was
being kept in a desiccator at room temperature until analysis.
Decoction: 1 L of boiling water was added over 100 g CS
powder previously weighed in an Erlenmeyer flask, the
mixture being maintained at 100 °C on an electric hob under
continuous stirring. The aqueous extract was hot filtered, cooled
at room temperature, and lyophilized, obtaining a dry CS
decoction (CSD). This extract was kept in similar conditions
with CSE until further analysis.
LC-DAD-ESI/MS Analysis of Phenolic
Compounds
The phenolic profile was determined by LC-DAD-ESI/MSn
(Dionex Ultimate 3000 UHPLC, Thermo Scientific, San Jose,
CA, United States). These compounds were separated and
identified using a method previously described (Bessada et al.,
2016). The obtained extracts were redissolved at a concentration
of 10 mg/ml with methanol: water (80:20, v/v) mixture. A double
online detection was performed using a DAD (280, 330, and
370 nm as preferred wavelengths) and a mass spectrometer (MS).
The MS detection was performed in negative mode, using a
Linear Ion Trap LTQ XL mass spectrometer (Thermo Finnigan,
San Jose, CA, United States) equipped with an ESI source.
The identification of the phenolic compounds was performed
based on their chromatographic behavior and UV-Vis and mass
spectra by comparison with standard compounds, when
available, and data reported in the literature giving a tentative
identification. Data acquisition was carried out with Xcalibur®
data system (Thermo Finnigan, San Jose, CA, United States). For
quantitative analysis, a calibration curve for each available
phenolic standard was constructed based on the UV-Vis
signal. For the identified phenolic compounds for which a
commercial standard was not available, the quantification was
performed through the calibration curve of the most similar
available standard. The results were expressed as mg/g of extract.
Total Phenolic Content (TPC) and Total
Flavonoid Content (TFC)
Samples redissolved in 70% ethanol with 5% DMSO at
concentration of 1 mg/ml were evaluated using protocols
previously described by Mocan et al. (2017). For TPC
determination, samples (20 µL) were mixed with diluted
Folin–Ciocalteu reagent (1:9, v/v) (100 µL) and shaken
vigorously. After 3 min, Na2CO3 solution (1%) (80 µL) was
added and the sample absorbance was read at 760 nm after
30 min incubation at room temperature. The total phenolic
content was expressed as milligrams of gallic acid equivalents
(mg GAE/g extract). In TFC assay, samples (100 µL) were mixed
with 2% aluminum trichloride methanolic solution (100 µL). The
sample absorbance was read at 415 nm after 10 min incubation at
room temperature. Rutin was used as a reference standard and
the total flavonoid content was expressed as milligrams of rutin
equivalents (mg RE/g extract).
Preliminary Biochemical Assessment of
Antioxidant Potential
Antioxidant Assays
The antioxidant potential of CSE and CSD was tested through
three complementary methods (DPPH, ABTS, and FRAP), the
protocols being previously described by Mocan et al. (2017),
Babotă et al. (2018), and Rusu et al. (2018). Samples were
redissolved in 70% ethanol with 5% DMSO obtaining 1 mg/ml
concentration; these were further analyzed using a
SPECTROstar® nano multi-detection microplate reader with
96-well plates (BMG Labtech, Ortenberg, Germany).
DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging
assay: Samples (30 μL) were mixed with a 0.004% methanol
solution of DPPH (270 μL). The absorbance was read at
517 nm after 30 min incubation at room temperature in the
dark. DPPH radical scavenging activity was expressed as
milligrams of Trolox equivalents (mg TE/g extract).
ABTS (2,2′-azino-bis(3-ethylbenzothiazoline)-6-sulfonic acid)
radical scavenging assay: Briefly, ABTS+ was produced directly by
reacting 7 mMABTS solution with 2.45 mMpotassium persulfate
and allowing the mixture to stand for 12–16 in the dark at room
temperature. Prior to beginning the assay, ABTS solution was
diluted with methanol to an absorbance of 0.700 ± 0.02 at
734 nm. Samples (20 μL) were added to ABTS solution
(10 mM and 200 μL) and mixed. The sample absorbance was
read at 734 nm after 30 min incubation at room temperature. The
ABTS radical scavenging activity was expressed as millimoles of
Trolox equivalents (mmol TE/g extract).
FRAP (ferric reducing antioxidant power) activity assay:
Samples (25 μL) were added to premixed FRAP reagent
(175 μL) containing acetate buffer (0.3 M, pH 3.6); 2,4,6-tris(2-
pyridyl)-s-triazine (TPTZ) (10 mM) in 40 mM HCl; and ferric
chloride (20 mM) in a ratio of 10:1:1 (v/v/v). Then, the sample
absorbance was read at 593 nm after 30 min incubation at room
temperature. FRAP activity was expressed as milligrams of Trolox
equivalents (mg TE/g extract).
Biological Activities Evaluation
Tyrosinase Inhibition
Sample solution (10 mg/ml, 25 μL) was mixed with tyrosinase
solution (40 μL, Sigma) and phosphate buffer (100 μL, pH 6.8) in
a 96-well microplate and incubated for 15 min at 25 °C. The
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reaction was then initiated with the addition of L-DOPA (40 μL,
Sigma). Similarly, a blank was prepared by adding sample
solution to all reaction reagents without enzyme (tyrosinase)
solution. The sample and blank absorbances were read at
492 nm after 10 min incubation at 25 °C. The absorbance of
the blank was subtracted from that of the sample and the
tyrosinase inhibitory activity was expressed as inhibition
percentage (IC50) (mg/ml), calculated for each sample and
kojik acid (positive control) (Uysal et al., 2017).
In vivo Studies on Diuretic Effect
Animals: Forty-eight adult male Charles River Wistar rats (Crl:
WI) with a medium weight of 151 ± 8 g were obtained from the
Practical Skills and Experimental Medicine Center of the “Iuliu
Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca,
Romania. The rats were housed in polycarbonate cages
(Tecniplast, Italy) and maintained under standard conditions
(22 ± 2 °C, a relative humidity of 45 ± 10%, and 12:12-h light: dark
cycle). The animals had free access to standard pelleted food
(Cantacuzino Institute, Bucharest, Romania) and filtered water
throughout the experiment, except for the day when the test
substances were administered. All experimental protocols were
approved by the Ethics Committee of the University (Approval
No. 168/April 7, 2017) and were conducted in accordance with
the EU Directive 86/609/EEC, which regulates the use of
laboratory animals for scientific research.
Diuretic and saluretic effects: Diuretic and saluretic effects of
CSE and CSD were tested by a method using isotonic saline
solution in order to achieve an optimal hydration (Kau et al.,
1984). Eight groups of Crl:WI rats (n  6) were used. The negative
control group of rats was treated orally by gavage only with
25 ml/kg isotonic saline solution (Braun, Germany), while the
positive control group was treated orally with 10 mg/kg
furosemide (Zentiva, Romania), a reference diuretic drug
dissolved also in a volume of 25 ml/kg isotonic saline solution.
Three groups of rats were treated orally with 125, 250, and
500 mg/kg CSE dispersed in the same volume of 25 ml/kg
isotonic saline solution, respectively, while other three groups
of rats received also by oral route 125, 250, and 500 mg/kg CSD
dispersed in 25 ml/kg isotonic saline solution.
After the substance administrations, rats were individually
placed in metabolic cages. The urine output (ml) was recorded for
each animal at two time intervals: 5 and 24 h after the
administration of a single dose from the tested substances
(Zhang et al., 2010). Diuretic action was calculated at 24 h as
the ratio of urine output in test groups to urine output in negative
control group. Diuretic activity was calculated at 24 h as the ratio
of urine output in test groups to urine output of the positive
control (reference) group.
Additionally, the saluretic effect of CSE and CSD was
investigated. The urinary concentration of sodium and
potassium ions (UNa and UK) was twice determined in the
collected urine samples, 5 and 24 h after the substance
administration, by a potentiometric method with selective
electrodes, using a VITROS 250 Chemistry System automatic
analyzer (Johnson and Johnson Clinical Diagnostic), being
expressed in mEq/kg (Pǎltinean et al., 2017). Furthermore, at
24 h, blood samples were obtained from all animals by retro-
orbital sinus puncture under ketamine/xylazine anesthesia and
serum concentration of sodium ions (SNa) was determined by
the same potentiometric method. Creatinine was
spectrophotometrically determined in the serum and urine at
670 nm, with the VITROS 250 Chemistry System automatic
analyzer, using a reaction which formed a triaryl imidazole
leuco dye. Fractional excretion of sodium ions (FENa) was
calculated with the formula
FENa  UNa × CRSSNa × CRU × 100
where UNa is the urine concentration of sodium ions, SNa is the
serum concentration of sodium ions, CRS is the serum
concentration of creatinine, and CRU the urine concentration
of creatinine (Păltinean et al., 2017).
Statistical Analysis
Data were expressed as mean values ± SD and were statistically
analyzed by the one-way ANOVA method. The differences
between the treated groups and the negative control group
were evaluated by Dunnett’s t-test using GraphPad Prism six
software (GraphPad Software, United States); p values <0.05
being considered statistically significant.
RESULTS AND DISCUSSION
Chemical Profile of the Extracts
Total Phenolic and Total Flavonoidic Content
Evaluation of TPC using the Folin–Ciocalteu method revealed a clear
difference between the two extracts based on extraction parameters
applied (Table 1). The 70% ethanol increased the extraction yield of
phenolic compounds in CSE (TPC  37.63 ± 2.75mg GAE/g extract)
by almost 50% in comparison with CSD (TPC  19.11 ± 1.52mg
GAE/g extract). A similar trend was observed for TPC, the values
obtained being 12.03 ± 0.72mg QE/g extract for CSE and 5.34 ±
0.23mg QE/g extract for CSD. Our results are in-line with those
previously reported in other studies. The evaluation of TPC in a
hydroalcoholic extract obtained after an optimized process by Demir
et al. revealed that TPC value was 26.60mg GAE/g extract (in
comparison with predicted value, 26.1mg GAE/g extract), optimal
conditions being 35% (v/v) ethanol percentage, 79°C, and 119min; for
the same extract, the TFC value was 2.26mg QE/g extract (Demir
et al., 2020). On the other hand, aqueous extracts confirmed the
presence of lower concentrations for bothTPC andTFC - 24.31± 0.86
to 39.54 ± 2.10 μg GAE/mL, respectively, 15.67 ± 0.68 to 23.17 ±
1.23 μg CE (catechin equivalents)/mL for infusions (Peixoto et al.,
2020). This can be correlated with low hydrophilicity of chemical
components from CS and encourage the use of ethanol–water
mixtures as extraction solvents in order to obtain phenolics-
enriched extracts.
LC-DAD/ESI–MS2 Analysis of Phenolic Profile
The solvents used and the extraction procedure play a significant
role on the chemical profile of the extracts and their bioactive
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potential. In this regard, an LC-DAD/ESI–MS2 technique was
employed to evaluate the phenolic compounds present in CSE
and CSD. Data of the retention time, λmax, pseudomolecular ion,
main fragment ions in MS2, and tentative identification of
phenolic acid and flavonoid derivatives are presented in
Table 2. Five major types of phenolic compounds were found
in CSE and CSD: phenolic acids (p-coumaroyl (1, 5, and 6),
caffeoyl (2, 3), and feruloyl 12) derivatives), flavanones (4, 7–9,
13–15, 18–20, and 24–27), flavones (10, 16, 21, and 22), flavanols
(11), and flavonols (17 and 23).
With the exception of p-coumaroylquinic acid (compound 1),
detected only in CSE−0.379 ± 0.004 mg/g, all phenolic acids were
detected in both extracts, being found in higher concentrations in
CSE than CSD. Compounds 1, 2, and 3 were identified as
hydroxycinnamoyl derivatives, taking into account their
fragmentation pattern and UV spectra at around λmax 
314–330 nm. Compounds 1 [(M–H)−at m/z of 337], 2, and 3
[(M–H)− at m/z of 353], all producing fragment ions with m/z
191, corresponding to the deprotonated quinic acid, so that they
could be clearly identified as quinic acid derivatives containing a
caffeic or coumaric acid units. Taking into account the following
the hierarchal key developed by Clifford et al. (2003) and Clifford
et al. (2006) for the identification of chlorogenic acid derivatives,
these compounds were identified as 3-p-coumaroylquinic, 4-O-
caffeoylquinic, and 5-O-caffeoylquinic acids. Compounds 5, 6
[(M–H)−at m/z of 325], and 12 [(M–H)− at m/z of 355] were
identified as coumaric acid hexoside and ferulic acid hexoside, all
indicating the losses of a hexosyl moieties (Bastos et al., 2015;
Bessada et al., 2016). The presence of phenolic acids in cherry
fruits hydroalcoholic extracts was previously confirmed by Bastos
et al. (2015) and Demir et al. (2020); cis-p-coumaroylquinic acid
(0.56 ± 0.01 mg/g) and trans-p-coumaroylquinic acid (0.23 ±
0.02 mg/g) were reported, the amounts being comparable with
our results obtained for determination of 3-p-coumaroylquinic
acid in CSE (0.379 ± 0.004 mg/g). As we mentioned, this
compound was identified only in CSE, probably due to
hydroalcoholic medium, emphasizing the importance of the
solvent for a better recovery of bioactive compounds.
The group of flavanones comprises the most representative
compounds identified in CSE and CSD. Compounds 13, 15, and
20, showed the same pseudomolecular ion [M–H]− at m/z 433,
thus presented a different retention time, therefore, being
tentatively identified as naringenin-O-hexoside isomers, despite
that the position and nature of the sugar could not be identified
for two of the isomers, thus compound 15 was assigned as
naringenin-7-O-glucoside, which was quantified as the main
component of CSE (4.57 ± 0.09 mg/g). Compound 4 [(M–H)−
at m/z 401], was detected in trace amounts in CSE, being
tentatively identified as naringenin-O-pentoside (releasing one
fragment at m/z 269, loss of a pentosyl moiety – m/z 132 u). To
the best of our knowledge, the presence of this compound in CS
extracts was not previously reported. Peaks 7–9 and 14 were
attributed to four isomers forms of aromadendrin-O-hexoside,
based on the presence of the common fragment at m/z 317
(aromadendrin – H). Aromadendrin derivatives have been
previously evidenced in CS hydroethanolic and water extracts
(Bastos et al., 2015). Compound 22 [(M–H)atm/z 417] released a
fragment at m/z 255 [(M–162) corresponding to the loss of
hexosyl moiety), being associated to a pinocembrin-7-
O-glucoside. Compounds 24 and 27 [(M–H) at m/z 447]
revealed a fragmentation patter that match with either
sakuranin (sakuranetin-5-O-glucoside) or dihydrowogonin-7-
O-glucoside, thus it was possible to assume one of the
identifications. Even though the flavanones were extracted
preferentially in hydroalcoholic medium, it was observed that
compounds 8, 9, and 19 were found in higher amounts in CSD
than CSE.
Three isoflavones were detected, such as compounds 18 and
19, which both revealed similar characteristics and were
tentatively assigned as genistein-O-hexoside. Nevertheless,
taking into account previous findings (Bastos et al., 2015),
compound 18 was identified as genistein-7-O-glucoside.
Compound 25 [(M–H) m/z 445] revealed a molecular weight
15 u higher than compounds 19 and 18, so it was assumed that it
might correspond to methylgenistein-O-hexoside.
The presence of several flavones was also confirmed in both
types of extracts. Quercetin-3-O-rutinoside (rutin), quercetin-3-
O-glucose, kaempferol-3-O-rhamnoside, isorhamnetin-3-O-
rhamnoside, and kaempferol-3-O-glucoside were identified in
comparison with the commercial standard. Among them, rutin
(quercetin-3-O-rutinoside) was found as the major compound
(1.01 ± 0.03 mg/g in CSE and 0.404 ± 0.003 mg/g in CSD).
Kaempferol-3-O-rhamnoside could be quantified only in CSD,
while kaempferol-3-O-glucoside was found in both extracts. The
presence of kaempferol glycosides in CS extracts was also
previously reported in similar studies (Bastos et al., 2015;
Aires et al., 2017; Jesus et al., 2019; Nastić et al., 2020). Only
one flavonol-type compound (peak 11) was found in the extracts;
it released a fragment ion at m/z 303 [(taxifolin – H); loss of a
hexosyl moiety, −162 u), being tentatively identified as taxifolin-
3-O-glucoside.
Overall, LC-DAD/ESI–MS2 analysis showed that the use of
70% ethanol as extraction solvent increased the extraction yield of
phenolic compounds, CSE containing various types of phenolics
TABLE 1 | Total phenolic and flavonoid content, DPPH and ABTS scavenging capacity, and ferric reducing ability of plasma (FRAP) of the extracts of CSE and CSD (values
expressed are means ± S.D. of three parallel measurements, p < 0.05).












CSE 37.63 ± 2.75 12.03 ± 0.72 30.02 ± 0.58 107.14 ± 1.43 111.87 ± 4.14
CSD 19.11 ± 1.52 5.34 ± 0.23 14.32 ± 2.00 55.65 ± 3.62 61.07 ± 2.83
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TABLE 2 | Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, tentative identification and quantification (mg/g of extract)













1 6.1 310 337 191 (100), 173 (15), 163 (20), 155 (5) 3-p-Coumarouylquinic
acid(A)
0.379 ± 0.004 nd –
2 6.5 322 353 191 (45), 179 (68), 173 (100), 161 (5), 135 (10) 4-O-Caffeoylquinic
acid(B)
0.69 ± 0.01 0.657 ± 0.002 <0.001
3 7.2 324 353 191 (100), 179 (13), 173 (5), 161 (5), 135 (5) 5-O-Caffeoylquinic
acid(B)
1.15 ± 0.01 0.290 ± 0.001 <0.001
4 7.6 287,316 sh 401 269 (100) Naringenin-O-
pentoside(C)
Tr nd –
5 8.6 310 325 163 (100) p-Coumaric acid
hexoside(A)
0.692 ± 0.001 0.238 ± 0.003 <0.001
6 10.0 310 325 163 (100) p-Coumaric acid
hexoside(A)
0.221 ± 0.004 0.120 ± 0.002 <0.001
7 11.2 283,320 sh 449 287 (100) Aromadendrin-O-
hexoside isomer 1(C)
1.27 ± 0.02 0.46 ± 0.01 <0.001
8 11.7 282,322 sh 449 287 (100) Aromadendrin-O-
hexoside isomer 2(C)
0.31 ± 0.01 0.37 ± 0.01 <0.001
9 12.7 283,320 sh 449 287 (100) Aromadendrin-O-
hexoside isomer 3(C)
0.019 ± 0.001 0.054 ± 0.001 <0.001
10 13.8 352 609 301 (100) Quercetin-
deoxyhexoside
hexoside(D)
Tr 0.027 ± 0.001 –
11 14.2 284,339 sh 465 303 (100) Taxifolin-3-
O-glucoside(E)
0.47 ± 0.01 0.125 ± 0.001 <0.001
12 15.2 320 355 193 (100), 149 (5), 134 (5) Ferulic acid hexoside(F) 0.133 ± 0.002 0.053 ± 0.001 <0.001
13 15.9 282,325 sh 433 271 (100) Naringenin-O-
hexoside isomer 1(C)
0.29 ± 0.01 0.139 ± 0.002 <0.001
14 16.3 283 449 287 (100) Aromadendrin-O-
hexoside isomer 4(C)
0.077 ± 0.001 0.046 ± 0.001 <0.001
15 16.9 283,325 sh 433 271 (100) Naringenin-7-
O-glucoside (C)
4.57 ± 0.09 0.71 ± 0.01 <0.001
16 17.9 353 609 301 (100) Quercetin-3-
O-rutinoside(D)
1.01 ± 0.03 0.404 ± 0.003 <0.001
17 19.1 351 463 301 (100) Quercetin-3-
O-glucose(G)
0.693 ± 0.004 0.14 ± 0.01 <0.001
18 19.9 260,330 sh 431 269 (100) Genistein-7-
O-glucoside(C)
0.0588 ± 0.002 0.0061 ± 0.0001 <0.001
19 20.4 281,330 sh 431 269 (100) Genistein-O-
hexoside(C)
Tr 0.043 ± 0.002 –
20 21.0 283,327 sh 433 271 (100) Naringenin-O-
hexoside isomer 2(C)
0.60 ± 0.01 0.078 ± 0.001 <0.001
21 21.2 340 593 285 (100) Kaempferol-3-
O-rhamnoside(D)
Tr 0.033 ± 0.001 –
22 22.2 350 623 315 (100) Isorhamnetin-3-
O-rhamnoside (D)
Tr Tr –
23 22.6 342 447 285 (100) Kaempferol-3-
O-glucoside(G)
0.520 ± 0.002 0.108 ± 0.003 <0.001
24 24.2 280,323 sh 447 285 (100), 270 (5) Dihydrowogonin 7-O-
glucoside/sakuranetin
5-O-glucoside(C)
0.44 ± 0.02 0.025 ± 0.001 <0.001
25 26.9 255,320 sh 445 283 (100), 268 (20) Methylgenistein
hexoside(C)
0.95 ± 0.01 0.078 ± 0.001 <0.001
26 29.9 283,320 sh 417 255 (100) Pinocembrin-7-
O-glucoside(C)
Tr Tr –
27 31.9 286,335 sh 447 285 (100), 270 (5) Dihydrowogonin 7-O-
glucoside/sakuranetin
5-O-glucoside(C)
Tr 0.0059 ± 0.0001 –
Total phenolic compounds 14.54 ± 0.12 4.205 ± 0.002 <0.001
Nd, not detected; tr-trace amounts. Standard calibration curves: A—p-coumaric acid (y  301950x + 6,966.7, R2  0.9999, LOD  0.68 μg/ml, and LOQ  1.61 μg/ml); B—chlorogenic
acid (y  168823x – 161,172; R2  0.9999, LOD  0.20 μg/ml, and LOQ  0.68 μg/ml); C—naringenin (y  18,433x + 78,903, R2  0.9998, LOD  0.17 μg/ml,, and LOQ  0.81 μg/ml);
D—quercetin-3-O-rutinoside (y  13,343x + 76,751, R2  0.9998, LOD  0.21 μg/ml, and LOQ  0.71 μg/ml); E—taxifolin (y  203766x – 208,383, R2  1, LOD  0.67 μg/ml, and
LOQ  2.02 μg/ml); F—ferulic acid (y  633126x – 185,462, R2  0.999, LOD  0.20 μg/ml, and LOQ  1.01 μg/ml); G—quercetin-3-O-glucoside (y  34,843x – 160,173, R2  0.9998,
LOD  0.21 μg/ml, and LOQ  0.71 μg/ml).
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in high amounts than CSD (Figure 1). The influence of extraction
method and extraction solvent on phenolic compounds recovery
from CS was previously studied by other authors. Nastić et al.
showed that the use of dual solvent mixture can enhance the
extraction efficiency, higher percentages of ethanol lead to a
decrease in the extraction yield; it can be noticed that, in this
study, CS extracts were obtained by pressurized liquid extraction
(PLE) and supercritical fluid extraction (SFE) (Nastić et al., 2020).
Aqueous extracts (infusion and decoction) represent a cheap and
household alternative option to exploit the benefits of CS as
source of phenolic compounds, based on ethnopharmacology
recommendations.
Preliminary Biochemical Assessment of
Antioxidant Potential
Antioxidant Assays
The free radical scavenging activity of CSE and CSD was
evaluated using the DPPH and ABTS radical scavenging
assays. As shown in Table 1, the value of DPPH radical
scavenging activity for CSE was 30.02 ± 0.58 mmol TE/g
extract, while for CSD decreased at 14.32 ± 2.00 mmol TE/g
extract; a similar trend was also observed in ABTS and FRAP
assay (107.14 ± 1.43 mg TE/g extract for CSE and 55.65 ± 3.62 mg
TE/g extract for CSD, respectively, 111.87 ± 4.14 mg TE/g extract
for CSE and 61.07 ± 2.83 mg TE/g extract for CSD). These
variations can be explained based on the major differences
observed in total and individual phenolic compounds
distribution in the extracts. It was previously reported that the
presence of p-coumaric acid and the p-coumaroylquinic acid
derivatives increased total antioxidant capacity of 70%
methanolic extracts obtained from CS (tested through ABTS
assay) (Aires et al., 2017). Moreover, a comparative evaluation
of DPPH scavenging activity and ferric reducing ability between
infusion, decoction, and hydroalcoholic extract of CS confirmed
the highest antioxidant potential for the last one correlated to the
higher phenolic compounds concentration found in this type of
extract (Bastos et al., 2015). A significant amount of experimental
data indicate that oxidative stress may contribute not only to
preexisting diseases like atherosclerosis or hypertension but it
may also generate oxidative damage to renal tubular cells,
reducing kidney functionality (Dennis and Witting, 2017)
Thus, a potential antioxidant activity could have
nephroprotective effects contributing to a normal renal




Tyrosinase is a copper-containing enzyme responsible for the
oxidation of tyrosine to L-DOPA and the hydroxylation of
L-tyrosine, with an important role in melanin synthesis (a
pigment that regulates skin color and plays a protective role
by absorbing ultraviolet sunlight and removing reactive oxygen
species from the skin), also responsible for browning of damaged
fruits and vegetables (Rusu et al., 2018). Recent studies confirmed
the link between tyrosinase inhibition and positive effects in
several degenerative diseases (i.e., Parkinson), proving the
importance of tyrosinase inhibitors as neuroprotective agents
(Hubert et al., 2016; Tan et al., 2016). In vitro evaluations shown
that tyrosinase can interfere with the activity of bradykinin and
vasopressin, two hormones that modulate diuresis and blood
FIGURE 1 | Phenolic profile of CSE recorded at 280 nm (A) and 370 nm (B).
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pressure through renin–angiotensin–aldosteron system (RAAS)
in a pH-dependent manner (BISSET, 1962).
In this regard, the evaluation of tyrosinase inhibitory capacity
of CS extracts (Table 3) revealed a superior potency for CSD
(IC50  3.03 ± 0.35 mg/ml) in comparison with CSE (IC50 
8.66 ± 1.23 mg/ml). The obtained results cannot be correlated
with the presence of phenolic compounds in the extracts, but
preliminary explains that some polar and hydrophilic secondary
metabolites from CS could exert a strong tyrosinase inhibitory
potential. It was previously reported that cherry juice (Cásedas et al.,
2016) and cherry tree bark extracts (Hubert et al., 2016) have a
moderate inhibitory activity on tyrosinase. To the best of our
knowledge, we evaluated for the first time tyrosinase inhibitory
potential of CS extracts; our results represent a start point for
further assessments of chemical composition of aqueous extracts
obtained from CS and encourage supplementary evaluation of the
molecular mechanisms responsible for anti-tyrosinase properties
of CS.
Diuretic Effect
As shown in Figure 2, the cherry stems extract (CSE) and cherry
stems decoction (CSD) produced a dose-dependent gradual increase
of the urine output, the effect being more intense at 24 h. Cherry
stems decoction (CSD) at 500mg/kg produced the most intense
diuretic effect with a urine output of 6.5 ± 0.35 ml at 24 h. The
reference loop diuretic, furosemide, augmented the urine output
from the first hours after the oral administration, the effect
increasing sharply at 5 h (7.38 ± 0.36ml), then reaching a plateau
(7.96 ± 0.37 ml), typical for a high ceiling diuretic drug. The diuretic
effect of cherry stems extract (CSE) and cherry stems decoction
(CSD), although inferior to furosemide, was more gradually
installed, which can be of importance in a series of chronic
cardiovascular diseases where a rapid diuretic effect is not desirable.
As shown in Table 4, the administration of cherry stems
extract (CSE) and cherry stems decoction (CSD) increased the
diuresis at 24 h in a dose-dependent manner. Rats treated with
CSE showed a statistically significant increase of urine output at
250 and 500 mg/kg, while rats treated with CSD showed
statistically significant results for all the three doses. The
diuretic action ranged from 1.09 to 1.45 for the animals treated
with CSE and from 1.26 to 1.56 for the animals treated with CSD.
The strongest diuretic activity was observed in the animals treated
with CSD at 500mg/kg, which showed 81% from the activity of
furosemide, the reference diuretic drug. Also, the cherry stems
extract (CSE) and cherry stems decoction (CSD) increased the
urinary excretion of Na+ and K+ ions (UNa, UK), the main
cationic electrolytes from the urine. As shown in Table 5 the
urinary excretion of the aforementioned electrolytes produced by
CSE and CSD was superior to the negative control group, and
presented a similar pattern with the diuretic effect, being more
intense in the 5–24 h time interval.
The most significant excretion of the tested electrolytes was
produced by the 500 mg/kg dose of CSD with UNa and UK values
of 3.84 ± 0.64 and 2.71 ± 0.32 mEq/kg, 24 h after the substance
administration. The calculated Na+/K+ ratio for CSE and CSD
treated groups did not show values above 10 at any moment of
determination, thus indicating a lack of a potassium-sparing
effect, similar with furosemide. On the contrary, both CSE and
CSD produced a clear kaliuretic effect. In our experiment, the
fractional excretion of sodium ions (FENa), defined as the
percentage of sodium ions filtered by the kidneys and not
reabsorbed, was calculated at 24 h. The fractional excretion of
sodium ions (FENa) is a valuable parameter which can provide
additional information on the tubular function, although the
TABLE 3 | Enzyme inhibitory effects of the extracts of CSE and CSD (values
expressed are mean ± S.D. of three parallel measurements, p < 0.05).
Probe ID IC50 (mg/ml)
CSE 8.66 ± 1.23
CSD 3.03 ± 0.35
Kojic acid 0.05 ± 0.01
FIGURE 2 | Effect of the cherry stems extract (CSE) and cherry stems decoction (CSD) on urine output recorded at 5 and 24 h in saline-loaded Crl:WI rats (*p < 0.05
vs. saline control).
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glomerular filtration rate and daily intake of sodium could also
influence its values (Schreuder et al., 2017). As expected, the
experiment showed a net increase of FENa (6.81%) for the
reference diuretic drug furosemide, which specifically
inhibits the sodium–potassium–chloride symporter in the
thick ascending limb of the loop of Henle, and a moderate
increase of FENa (2.14–2.42 and 3.72–4.58%) for CSE and CSD
at doses of 250 and 500 mg/kg, also suggesting a tubular
mechanism of action responsible for the diuretic effect of
the tested cherry stems preparations.
The diuretic activity of powdered cherry stems (administered as
capsules at an equivalent dose of 2.0 g of the plant per person) was
previously evaluated in healthy human subjects, urinary volume,
urinary electrolyte concentration (sodium, potassium, chloride, and
calcium), and the osmolality beingmonitored (Hooman et al., 2009).
The study revealed a mild diuretic effect for CS and a slight increase
for urinary excretion of calcium, sodium, and chloride, concluding
that the drug can be used as diuretic agent, but with precautious in
those patients, and also in patients having any disorders associated
with calcium, sodium, and/or chloride deficiency (especially in those
with urolithiasis because of rising calcium excretion). A comparison
between those results and our experimentally output regarding
diuretic activity of CS reveals a similar trend for both type of
tested CS-derived products. Our study represents the first report
about diuretic and saluretic activity of the extracts obtained from CS
and correlates this potential with the presence of phenolic secondary
metabolites as main constituents of both hydroalcoholic and
aqueous preparations.
CONCLUSION
Based on ethnopharmacological evidence, cherry stems (CS)
preparations (hydroalcoholic extract and decoction) were
evaluated for their phenolic profile and several bioactivities.
Overall, the presence of phenolic secondary metabolites was
confirmed in both extracts, the highest concentrations being
found in hydroalcoholic extract. Flavonoids were the main
type of phenolic compounds identified in the extracts,
naringenin derivatives being quantified in high amounts.
Hydroalcoholic extract exerted an important antioxidant
activity, while tyrosinase inhibitory potential and diuretic
activity were superior for decoction.
Our findings suggest that cherry stems are a valuable and
less exploited by-product rich in phenolic secondary
metabolites, with potential applications as a mild and safe
diuretic agent. Even through traditional medicine
recommends the use of aqueous preparations obtained
from CS as adjuvant therapy in urinary tract disorders,
hydroalcoholic extracts could represent an improved
alternative, showing a similar diuretic potential.
Nevertheless, future investigations need to be performed in
TABLE 4 | Parameters of the diuretic effect in saline-loaded Crl:WI rats treated with cherry stems extract (CSE) and cherry stems decoction (CSD). Values of urine output are
expressed as Mean ± SD (n  6).
Group (dose) Urine output at 24 h
(ml)
Diuretic action Diuretic activity
Saline control 4.16 ± 0.37 – –
Furosemide (10 mg/kg) 7.96 ± 0.37 1.91 1
CSE 125 mg/kg 4.55 ± 0.65 1.09 0.57
CSE 250 mg/kg 5.61 ± 0.38a 1.34 0.70
CSE 500 mg/kg 6.05 ± 0.33a 1.45 0.76
CSD 125 mg/kg 5.25 ± 0.32a 1.26 0.65
CSD 250 mg/kg 6.11 ± 0.21a 1.46 0.76
CSD 500 mg/kg 6.50 ± 0.35a 1.56 0.81
ap < 0.05 vs. saline control.
TABLE 5 | Effect of the cherry stems extract (CSE) and cherry stems decoction (CSD) on urinary excretion of sodium (UNa) and potassium (UK) 5 and 24 h after the substance
administration, fractional excretion of sodium (FENa), and the ration Na/K in saline loaded Crl:WI rats.













Saline control 1.43 ± 0.31 1.13 ± 0.27 1.94 ± 0.37 1.55 ± 0.42 1.32 1.25
Furosemide (10 mg/kg) 5.59 ± 0.78* 4.91 ± 0.41* 6.32 ± 0.84* 5.31 ± 0.44* 6.81 1.19
CSE (125 mg/kg) 1.83 ± 0.35 1.57 ± 0.29 2.58 ± 0.61 1.96 ± 0.59 1.97 1.31
CSE (250 mg/kg) 2.41 ± 0.66* 1.83 ± 0.31* 2.88 ± 0.59* 2.01 ± 0.73* 2.14 1.43
CSE (500 mg/kg) 2.89 ± 0.75* 2.02 ± 0.89* 3.03 ± 0.88* 2.14 ± 0.69* 2.42 1.41
CSD (125 mg/kg) 2.15 ± 0.39 1.83 ± 0.73 2.87 ± 0.83 2.08 ± 0.68 2.05 1.37
CSD (250 mg/kg) 2.49 ± 0.44 2.12 ± 0.29 3.42 ± 0.87 2.39 ± 0.46 3.72 1.43
CSD (500 mg/kg) 3.11 ± 0.82 2.36 ± 0.55 3.84 ± 0.64 2.71 ± 0.32 4.58 1.41
Values of UNaV and UKV are expressed as Mean ± SD (n  6) (*p < 0.05 vs. saline control).
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order to elucidate the intimate mechanisms responsible for
CS pharmacological potential.
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Švarc-Gajić, J., Cerdà, V., Clavijo, S., Suárez, R., Mašković, P., Cvetanović, A., et al.
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